Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05147558Phase 2Active Not Recruiting
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
Advanced Uterine CarcinosarcomaUterine Carcinosarcoma
PrincipalinvestigatorStart date: 2021-12-23
NCT03285152Not ApplicableCompleted
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
Endometrial Cancer
PrincipalinvestigatorStart date: 2018-02-19
NCT02549989Phase 2Completed
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Endometrial CancerRecurrent Endometrial Cancer
PrincipalinvestigatorStart date: 2015-09-01
NCT03015129Phase 2Completed
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
Endometrial CancerEndometrial Cancer RecurrentEndometrial Carcinoma+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05147558Phase 2PrincipalInvestigator

A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma

Advanced Uterine CarcinosarcomaUterine Carcinosarcoma
Active Not Recruiting
NCT03285152Not ApplicablePrincipalInvestigator

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

Endometrial Cancer
Completed
NCT02549989Phase 2PrincipalInvestigator

Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

Endometrial CancerRecurrent Endometrial Cancer
Completed
NCT02269293Phase 1PrincipalInvestigator

Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers

Endometrial CancerOvarian Cancer
Completed
NCT03015129Phase 2PrincipalInvestigator

A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

Endometrial CancerEndometrial Cancer RecurrentEndometrial Carcinoma+2 more
Completed

All 5 trials loaded